UPDATE: JPMorgan Downgrades Orchard Therapeutics (ORTX) to Neutral
Tweet Send to a Friend
(Updated - August 18, 2021 3:58 AM EDT)
JPMorgan analyst Anupam Rama downgraded Orchard Therapeutics (NASDAQ: ORTX) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama downgraded Orchard Therapeutics (NASDAQ: ORTX) from Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
